Gainers
- Axcella Health AXLA shares rose 64.0% to $0.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $51.8 million.
- Baudax Bio BXRX stock increased by 30.15% to $4.1. The market value of their outstanding shares is at $2.2 million.
- Novo Integrated Sciences NVOS stock increased by 26.01% to $0.16. The market value of their outstanding shares is at $9.2 million.
- Intelligent Bio Solutions INBS shares increased by 22.33% to $1.26. The company's market cap stands at $23.1 million.
- bioAffinity Technologies BIAF shares rose 16.98% to $1.86. The company's market cap stands at $15.5 million.
- Genetic Technologies GENE shares moved upwards by 12.8% to $1.11. The company's market cap stands at $17.0 million.
Losers
- LogicMark LGMK shares fell 35.9% to $0.23 during Tuesday's pre-market session. The company's market cap stands at $2.2 million.
- Allarity Therapeutics ALLR shares decreased by 17.59% to $0.24. The market value of their outstanding shares is at $3.4 million.
- Rockwell Medical RMTI stock declined by 14.29% to $1.8. The market value of their outstanding shares is at $20.9 million.
- Tenax Therapeutics TENX stock decreased by 11.02% to $2.29. The market value of their outstanding shares is at $5.1 million.
- electroCore ECOR shares fell 8.7% to $0.36. The company's market cap stands at $25.7 million.
- Sunshine Biopharma SBFM stock fell 8.25% to $0.89. The market value of their outstanding shares is at $20.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ALLRAllarity Therapeutics Inc
$1.05-%
Edge Rankings
Momentum
9.08
Price Trend
Short
Medium
Long
BIAFbioAffinity Technologies Inc
$0.2859-0.31%
ECORelectroCore Inc
$7.35-1.34%
INBSIntelligent Bio Solutions Inc
$1.825.20%
LGMKLogicMark Inc
$0.0036012.5%
NVOSNovo Integrated Sciences Inc
$0.00350-97.7%
RMTIRockwell Medical Inc
$1.142.70%
SBFMSunshine Biopharma Inc
$1.46-2.01%
TENXTenax Therapeutics Inc
$5.930.51%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.